A New Dynamic

A New Dynamic With an eye toward host-pathogen interactions, can a Penn State center predict and prevent the next pandemic? By Brendan Borrell ARTICLE EXTRAS 1 "Our vision really is to have a systems approach to disease," says Hudson. "Issues that go from intracellular interactions between viruses and cells right the way through to pandemics, something we call the protein-to-pandemic link." Pathogens don't just interact, they evol

Written byBrendan Borrell
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

With an eye toward host-pathogen interactions, can a Penn State center predict and prevent the next pandemic?
By Brendan Borrell

ARTICLE EXTRAS

"Our vision really is to have a systems approach to disease," says Hudson. "Issues that go from intracellular interactions between viruses and cells right the way through to pandemics, something we call the protein-to-pandemic link."

Pathogens don't just interact, they evolve. In the 1960s, optimistic researchers had declared victory over infectious disease. It was time to move on to heart disease, cancer, and psychiatric disorders. That bubble burst in 1981 with the recognition of HIV. The disease had leapt from nonhuman primates to humans and continued to evolve and diversify in ways scientists still don't understand.

Bryan Grenfell began his career on this first wave of disappointment. He worked with Roy Anderson, an early pioneer of disease ecology at Imperial College London, to build mathematical models of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies